Anti-venom therapies neutralize snake, spider, and scorpion venoms through polyclonal immunoglobulin fragments administered intravenously saving over 100,000 lives annually from envenomation. The global anti-venom market size was valued at USD 1.28 billion in 2024 and is projected to grow from USD 1.38 billion in 2025 to reach USD 2.57 billion by 2033, growing at a CAGR of 8.9% during...